Increased maternal non-oxidative energy metabolism mediates association between prenatal DEHP exposure and offspring ASD symptoms: a birth cohort study
Authors:
- Sarah ThomsonSTSarah Thomson
- Katherine DrummondKDKatherine Drummond
- Anne-Louise PonsonbyAPAnne-Louise Ponsonby
- the Barwon Infant Study Investigator GroupTGthe Barwon Infant Study Investigator Group
Preprint
Abstract
Prenatal phthalate exposure has previously been linked to the development of autism spectrum disorder (ASD). However, the underlying biological mechanisms remain unclear. We investigated whether maternal and child central carbon metabolism is involved as part of the Barwon Infant Study, a population-based birth cohort of 1074 Australian children. We estimated phthalate daily intakes using third-trimester urinary phthalate metabolite concentrations and other relevant indices. The metabolome of maternal serum in the third trimester, cord blood at birth and child plasma at 1 year were measured by nuclear magnetic resonance. We used the Small Molecule Pathway Database and principal component analysis to construct composite metabolite scores reflecting metabolic pathways. ASD symptoms at 2 and 4 years were measured by subscales of the Child Behavior Checklist and the Strengths and Difficulties Questionnaire, respectively. Multivariable linear regression analyses demonstrated (i) associations between higher prenatal di(2-ethylhexyl) phthalate (DEHP) levels and increased activity in maternal non-oxidative energy metabolism pathways, specifically non-oxidative pyruvate metabolism and the Warburg Effect, and (ii) associations between increased activity in these pathways and increased offspring ASD symptomology at 2 and 4 years of age. Mediation analyses suggested that part of the mechanism by which higher prenatal DEHP exposure influences the development of ASD symptoms in early childhood is through a maternal metabolic shift in pregnancy towards non-oxidative energy pathways, which are inefficient compared to oxidative metabolism. Interventions targeting maternal metabolic activity in pregnancy may be beneficial in reducing the potential risk to the developing fetus.Keywords
This publication has 77 references indexed in Scilit:
- Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood AutismJAMA, 2013
- Phthalate Exposure Changes the Metabolic Profile of Cardiac Muscle CellsEnvironmental Health Perspectives, 2012
- Combined Transcriptomic–1H NMR Metabonomic Study Reveals That Monoethylhexyl Phthalate Stimulates Adipogenesis and Glyceroneogenesis in Human AdipocytesJournal of Proteome Research, 2011
- Metabolomics of Oxidative Stress in Recent Studies of Endogenous and Exogenously Administered Intermediate MetabolitesInternational Journal of Molecular Sciences, 2011
- Endocrine disruptors and childhood social impairmentNeuroToxicology, 2011
- Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6–8 years of ageNeuroToxicology, 2009
- High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolismThe Analyst, 2009
- Exposure assessment of phthalate esters in Japanese pregnant women by using urinary metabolite analysisEnvironmental Health and Preventive Medicine, 2009
- Characterization of Phthalate Exposure among Pregnant Women Assessed by Repeat Air and Urine SamplesEnvironmental Health Perspectives, 2008
- Autism and environmental genomicsNeuroToxicology, 2006